Efficacy of onabotulinumtoxinA and abobotulinumtoxinA at the conversion ratio of 1:3 in a patients who have asymmetry resulted frm facial palsy.
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Bell palsy
- Focus Therapeutic Use
- 24 Dec 2015 New trial record